Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Winningham Rick E Create: Alert

All | News | Filings
Date FiledTypeDescription
08/22/2023 4 Winningham Rick E (CEO) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Paid exercise price by delivering 15,804 shares @ $9.7, valued at $153.3k
08/15/2023 4 Winningham Rick E (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 3,075 shares @ $0
Sold 1,241 shares @ $138.1584, valued at $171.5k
08/14/2023 144 Form 144 - Report of proposed sale of securities:
05/23/2023 4 Winningham Rick E (CEO) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Paid exercise price by delivering 15,804 shares @ $11.21, valued at $177.2k
03/03/2023 4 Winningham Rick E (CEO) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Granted 330,000 shares @ $0
02/22/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/23/2022 4 Winningham Rick E (CEO) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Paid exercise price by delivering 22,710 shares @ $9.61, valued at $218.2k
11/23/2021 4 Winningham Rick E (CEO) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Paid exercise price by delivering 11,404 shares @ $8.36, valued at $95.3k
08/24/2021 4 Winningham Rick E (CEO) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Paid exercise price by delivering 11,404 shares @ $14.05, valued at $160.2k
08/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/02/2021 4 Winningham Rick E (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 2,246 shares @ $0
05/24/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2021 4 Winningham Rick E (CEO) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Granted 170,000 shares @ $0
11/24/2020 4 Winningham Rick E (CEO) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Paid exercise price by delivering 13,946 shares @ $17.21, valued at $240k
08/24/2020 4 Winningham Rick E (CEO) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Paid exercise price by delivering 13,946 shares @ $18.22, valued at $254.1k
08/10/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/22/2020 4 Winningham Rick E (CEO) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Paid exercise price by delivering 13,946 shares @ $26.67, valued at $371.9k
02/24/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/05/2020 4 Winningham Rick E (CEO) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Granted 170,000 shares @ $0
Granted 168,000 shares @ $0
11/22/2019 4 Winningham Rick E (CEO) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Paid exercise price by delivering 8,678 shares @ $17.6, valued at $152.7k
08/22/2019 4 Winningham Rick E (CEO) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Paid exercise price by delivering 8,678 shares @ $21.51, valued at $186.7k
08/12/2019 4 Winningham Rick E (Director) has filed a Form 4 on Jazz Pharmaceuticals plc
Txns: Granted 1,920 shares @ $0
Sold 726 shares @ $135.6504, valued at $98.5k
Granted 4,805 options to buy @ $137.12, valued at $658.9k
05/22/2019 4 Winningham Rick E (CEO) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Paid exercise price by delivering 8,678 shares @ $19.84, valued at $172.2k
02/22/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/07/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/05/2019 5 Form 5 - Annual statement of changes in beneficial ownership of securities:
11/21/2018 4 Winningham Rick E (CEO) has filed a Form 4 on Theravance Biopharma, Inc.
Txns: Paid exercise price by delivering 15,557 shares @ $24.79, valued at $385.7k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy